Lipid-based Codelivery of Doxorubicin and siRNA PD-L1, as a Multi-function Chemo-immunotherapy, Selective to Pancreatic Cancer via its MUC1 Overexpression
An animation of how the project works, drawn from the research. The numbers are the measured results from the project.
2025 · ISEF 2nd Place Grand Award · Provisional patent filed · CT-JSHS 1st Place Oral Presentation · National STEM Festival Finalist & Champion · CSEF 1st Place, Biotechnology · CSEF 1st Place, Engineering